Mark Lazarev Selected Research

Mark Lazarev Research Topics

10	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2023 - 04/2012
5	Inflammation (Inflammations) 01/2023 - 04/2012
5	Crohn Disease (Crohn's Disease) 01/2023 - 07/2013
3	Ulcerative Colitis 09/2022 - 01/2018
3	Colitis 07/2020 - 10/2012
3	Neoplasms (Cancer) 12/2014 - 08/2011
2	COVID-19 11/2022 - 02/2021
2	Necrosis 01/2022 - 02/2016
2	Adenoma (Adenomas) 12/2014 - 08/2011
2	Colorectal Neoplasms (Colorectal Cancer) 04/2012 - 08/2011
1	Dysbiosis 01/2023
1	Cough 09/2022
1	Fistula 12/2021
1	Disease Progression 01/2017
1	Measles 11/2015
1	Pain (Aches) 11/2008
1	Chronic Pancreatitis 11/2008
1	Pancreatitis 11/2008

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2011
3	Calcibiotic Root Canal SealerIBA 12/2014 - 08/2011
2	Messenger RNA (mRNA)IBA 08/2023 - 01/2022
2	mRNA VaccinesIBA 08/2023 - 12/2021
2	GlucocorticoidsIBA 11/2022 - 02/2021
2	CytokinesIBA 02/2016 - 11/2015
1	LipidsIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	LigandsIBA 07/2022
1	AntibodiesIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 12/2021
1	Ad26COVS1IBA 12/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 06/2017
1	InflammasomesIBA 06/2017
1	InterleukinsIBA 02/2016
1	ChemokinesIBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 11/2008